Clinical Trials Directory

Trials / Terminated

TerminatedNCT03161509

Pharmacokinetics of Paracetamol and Antiepileptic Drugs After Sleeve Gastrectomy

Effect of Sleeve Gastroctomy on Pharmacokinetics of Paracetamol and Antiepileptic Drugs

Status
Terminated
Phase
Phase 4
Study type
Interventional
Enrollment
2 (actual)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Accepted

Summary

Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol and antiepileptic drugs before and 6 months after sleeve gastrectomy.

Detailed description

Sleeve gastrectomy may affect drug pharmacokinetics in several potential ways. We will measure pharmakokinetics of paracetamol (in consenting subjects that are undergoing sleeve gastrectomy) and antiepileptic drugs (in consenting subjects that are chronically treated by a stable dose) before and 6 months after sleeve gastrectomy in 10 subjects. Blood tests will be taken for drug levels before and 4-8 times after the subject takes the drug. A pharmacokinetic curve will be calculated and compared for each subject between prior to surgery and after surgery.

Conditions

Interventions

TypeNameDescription
DRUGParacetamolsingle dose of 1 gr paracetamol
DRUGAntiepileptic (either carbamazepine, lamotrigine, phenytoin or valproic acid)Single dose of antiepileptic drug (either carbamazepine, lamotrigine, phenytoin or valproic acid) for which the participant is taking chronically in stable dose

Timeline

Start date
2017-07-01
Primary completion
2018-12-01
Completion
2019-01-01
First posted
2017-05-19
Last updated
2021-09-24

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT03161509. Inclusion in this directory is not an endorsement.